|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1,6-fucose binding lectin
Allergy and Inflammation Research, Division of Infection Inflammation and Repair, University of Southampton, Southampton General Hospital, Southampton, United Kingdom
Submitted 3 August 2006 ; accepted in final form 5 October 2006
| ABSTRACT |
|---|
|
|
|---|
1,6-linked fucose residues. Addition of unconjugated or FITC-labeled AAL reduced the rate of epithelial repair to approximately one-third of control values as measured by image analysis while cell viability was maintained. Pulse labeling with AAL-FITC for 30 min followed by incubation in AAL-free medium caused similar inhibition of repair but could be reversed by addition of fucose up to 7 h after AAL removal. By confocal microscopy, AAL binding was found to be on the apical, but not basolateral, surfaces of cells, and internalization of the labeled lectin was seen. Preincubation of the lectin with fucose prevented this effect. Ulex europeaus I lectin, which is also fucose specific, resulted in similar binding to the cells and internalization, but it did not affect the speed of the repair process. We conclude that
1,6-fucose binding sites play an important role in epithelial repair. Better understanding of this process will provide a deeper insight into the crucial mechanisms of epithelial repair. airway; endocytosis; epithelium; inhibition
Although neither the processes governing epithelial repair nor the changes in disease are fully understood, many of the key interactions between epithelial cells as well as their interaction with cells of the immune system are based on glycoconjugate binding or are modified by changes in cell surface glycoconjugates. For example, Pace et al. (27) established that human Galectin I induced apoptosis by binding to a specific set of cell surface glycoproteins resulting in a dramatic redistribution of surface glycoproteins in those cells that subsequently died. Fucose-containing glycoconjugates are widely expressed in mammals, and a number of key biological processes are already attributed to them. The Lewis antigens (containing
1,3-linked fucose) are essential for the correct functioning of the immune system, whereas H antigen, an
1,2-fucosylated precursor of the Lewis antigen, is increased in dermal wound healing. Recent studies indicating that the spatial modulation of Notch family receptors during development is mediated by receptor fucosylation by the glycosyltransferase Fringe emphasize the potential for a central role of fucose in cell signaling (23).
The conformation of the fucose linkage is also biologically important and provides a further level of discrimination: the role of glycoconjugates can only be fully understood if we know their structure. During leukocyte binding to endothelium at sites of inflammation, the
1,3-linked, fucose-containing glycoconjugates sialyl LewisA and sialyl LewisX are specific ligands for the cell adhesion molecule E-selectin, which is expressed on vascular endothelial cells. Selectins tether the leukocytes to the endothelium (22) and are an essential prerequisite for the subsequent cell crawling and extravasation required for their movement to a site of inflammation. Increased H antigen levels in dermal wound healing (9) indicate a wound-related increase in the activity of the secretor-independent
1,2-fucosyltransferase. Kauffmann and colleagues (18) have shown that the absence of Lewis antigens is associated with higher prevalence of asthma and wheezing.
Lectins are naturally occurring glycoconjugate binding molecules that can be isolated from a wide variety of plants and animals and provide exquisitely selective tools to identify or block specific glycoconjugate motifs. Whereas many lectins bind to a range of sugar structures, some are selective for particular sugars in particular linkages (37). The lectin from the mushroom Aleuria aurantia (AAL) has a high affinity for
1,6-linked fucose found in disaccharides, oligosaccharides, and glycoproteins. AAL comprises two identical non-glycosylated subunits of 36 kDa. In studies of binding to immobilized AAL, only
1,6-linked, fucose-containing glycoconjugates and terminal unsubstituted fucose
1,2-galactose linkages bound to AAL (44). In the same study, passage of
1,2- and
1,3-fucose-containing oligosaccharides through an AAL column was retarded, but these sugars did not bind. Thus in practice AAL can be considered to be a highly specific tool for identifying
1,6-fucose residues, and there have been a number of studies using AAL in this context (34, 38, 42). In human respiratory tract, Dorscheid and colleagues (11) have shown that AAL bound to the surface of nonsecretory columnar and basal epithelial cells but not to the basement membrane. In the same study, Anguilla anguilla and Lotus tetragonolobus lectin binding sites (both fucose specific but with different linkages) were found on columnar, but not basal, cells, implicating a link between
1,6-fucose linkages and a differentiated epithelial cell phenotype.
In this study, we demonstrate the importance of
1,6-linked fucose in the repair of damage to epithelial cell layers. These observations have important implications not only in understanding the epithelial injury-repair cycle but also for identifying targets for novel drug development in diseases such as asthma.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Lectins.
Unconjugated lectin from AAL and the lectin from Furze Gorse [Ulex europeaus (UEA I)] conjugated to FITC were supplied by Vector Laboratories (Peterborough, UK). Both of these lectins are fucose specific but have preferences for different fucose linkages. AAL binds preferentially to
1,6-linked fucose with a secondary specificity for
1,3-linked fucose (10, 44), whereas UEA I binds to
1,2-linked fucose and poorly or not at all to
1,6- and
1,3-linked fucose (5, 35). AAL-FITC was produced by conjugating AAL with FITC using a Fluorotag FITC conjugation kit (Sigma-Aldrich, Poole, Dorset, UK) following the manufacturer's directions.
Lectin addition. Unconjugated AAL was added to cultures at a concentration of 3 µg/ml medium for 24 h. A dose titration with varying concentrations between 1 and 10 µg/ml showed that at 3 µg/ml, wound repair was maximally inhibited while viability was always above 85% (results not shown). Following a similar titration, AAL conjugated to FITC was added to cultures at a concentration of 5 µg/ml for 24 h. A pulsed addition of AAL-FITC at 50 µg/ml for 30 min had no effect on the viability of the monolayers and was therefore used to saturate the AAL binding sites on the cells. Following this, the monolayer was thoroughly rinsed, and normal medium was replaced and left for 24 h.
UEA I-FITC was added to cultures at the same concentration as AAL-FITC (5 or 50 µg/ml). Media in control cultures were changed at the same time points as the treated cultures but received no lectin additions to the culture medium. Lectin specificity control experiments were undertaken by preincubating the lectins with L-fucose (0.3 M, Sigma-Aldrich) for 30 min before addition to the culture medium. The final concentration of fucose after addition to the culture medium was 12 mM.
Lectin cytochemistry. To determine whether the lectins bound to the surface of the cells, lectins directly conjugated to FITC at a concentration of 50 µg/ml in medium were added to cultures of cells grown on glass coverslips for 30 min at room temperature. The coverslips were either rinsed in PBS at pH 7.4 or washed and placed in normal medium for a further 24 h of culture. After being rinsed in PBS, they were then fixed in cold methanol for 10 min at 5°C, rinsed again in PBS, and mounted in AF1 solution (Citifluor, London, UK).
Fluorescence microscopy. Labeling with fluorescent counterstains and lectins was assessed by viewing cells on coverslips using a Leica DMRBE fluorescence microscope with a Hoechst, FITC, or tetramethyl rhodamine iso-thiocyanate filter block. A Leica TCS SP2 confocal microscope was used for confocal imaging when the cells were fixed and counterstained with propidium iodide (5 µg/ml for 5 min) before examination.
Estimation of growth. KS400 Image Analysis software (Imaging Associates, Thame, UK) was used to measure the areas of initial damage and the area remaining after repair in the cultures. The area of damage in the images was traced using a Calcomp DrawingBoard III digitizer tablet, and the area of repair was calculated by subtracting the area of damage remaining after 24 h from the original area of damage at time 0. Each experiment was repeated a minimum of three times, and statistical comparisons were made using a two-tailed unpaired t-test.
| RESULTS |
|---|
|
|
|---|
|
|
|
AAL binds to the surface of the cells. AAL-FITC was distributed throughout the repairing epithelium (Fig. 4). After addition to the culture medium, AAL-FITC bound rapidly to the surface of the cells. After 30 min of incubation with AAL-FITC, the majority of cells showed surface labeling with some variability in the intensity of labeling and one or two cells in each field without detectable labeling (Fig. 4A). Figure 5A shows a confocal image of a similar monolayer of 16HBE cells, again 30 min after addition of AAL-FITC. Fluorescence was uniformly distributed on the apical surfaces of the cells and occurs above the nuclei. This labeling covered the majority of the apical surfaces but was not visible on the basolateral surfaces. The single x-y confocal sections in Fig. 5A show more apparent variability in apical cell surface labeling, as not all the apical surface is included in this plane. The z-plane reconstruction from the confocal sections in Fig. 5A demonstrates the distribution of labeling more clearly. At this stage, no intracellular fluorescence was visible. Cells observed 24 h after the AAL-FITC was replaced with medium showed that all the AAL-FITC was now within the cells, as seen in the confocal image (Fig. 5B). The fluorescent granules were generally in a perinuclear position and seen as small granules or aggregates of granules. No fluorescence remained on the apical surfaces of the cells as shown by z-plane images constructed from the confocal image stack. This change in pattern and location of the labeled granules below the level of the nuclei indicated that the AAL-FITC had been internalized.
|
|
| DISCUSSION |
|---|
|
|
|---|
1,6-fucose binding lectin AAL to damaged monolayers of epithelial cells blocks, or greatly inhibits, the normal ability of the layer to repair. Normally, repair of an experimental wound in this system (1) would be complete in 24 h, but in the presence of AAL, repair is not complete in 48 h, and the rate of repair drops to approximately one-third of the original. Although we have used an in vitro model in these studies, it is known from work in animal systems that similar processes occur in vivo (12). Any delay in repairing minor damage would significantly increase the risk of infection as there is already likely to be an increased danger of infection at sites of trauma. The AAL binding sites therefore appear to have an important role in the normal epithelial repair process.
AAL is an exceptionally well-characterized lectin from the edible orange cup mushroom (Aleuria aurantia). It contains 312 amino acids and is multivalent with a high binding affinity for fucose glycoconjugates (10, 43). It has been reported to have highest affinity for
1,6-fucose structures, particularly those that also contain an
1,3-fucose linkage (10). The specificity of the inhibitory effect of AAL on repair is further supported by the ability to block the effect using fucose preincubation and also by the lack of inhibition of repair caused by the binding of the lectin UEA I, which is known to bind predominantly to
1,2-linked fucose residues but very poorly or not at all to
1,6- and
1,3-linked fucose residues (5, 35). AAL preincubation with fucose before addition to cells prevents binding of AAL to the cell surface and indicated that binding was necessary for inhibition. The binding of AAL appears to be complete within 30 min, and sufficient AAL binds within this time to provide maximal inhibition at 24 h even in the absence of any further AAL in the cell medium. Comparison of the effect of native AAL and AAL conjugated to fluorescein (AAL-FITC) indicated that the effect on epithelial repair was indistinguishable in this model. The use of FITC-labeled AAL (AAL-FITC) therefore provides a useful tool to track the location of the AAL during the treatments.
The reduced speed of repair following AAL binding, while cell viability is maintained, suggests that binding affects the regulation or implementation of one or more of the complex steps involved in regenerating an epithelium after damage. The fact that some repair does occur and that in time it is completed confirms the viability of the cells while indicating either that binding is not sufficient to give complete inhibition or that there are multiple redundant processes that can bring about repair, albeit at different rates. If cells incubated with a 30-min pulse of AAL were treated with fucose up to 7 h later, normal repair was seen, whereas after this time, significant inhibition of repair occurred. This unexpected result suggests that AAL has the most significant inhibitory effect on repair during the period starting 7 h after repair is initiated. At 7 h, much of the bound AAL has internalized, implicating an interaction within an internalization compartment of the cell. This pattern and time course of labeling is consistent with AAL endocytosis rather than reaction with fucosylated molecules synthesized de novo within the cell. This might reflect the occurrence of an important fucose-dependent interaction at this site.
To effectively interpret the underlying effects of AAL, it is important to understand not only the dynamics of the effect but also the subcellular localization of the AAL that causes it. The initial AAL-FITC binding pattern is consistent with binding to only the apical epithelial surface, and confocal imaging clearly confirms this. In the subsequent 28 h, the fluorescent label shows a progressively more vesicular pattern of staining consistent with endocytosis, and by 24 h, no surface labeling remains, with confocal microscopy showing fluorescent intracellular vesicles. Although it does not inhibit repair, FITC-labeled UEA I (which is also fucose binding) shows a similar surface-labeling pattern initially followed by internalization and the formation of intracellular vesicles. There are some minor differences in the pattern of vesicular labeling between AAL and UEA that could reflect different subcellular compartmentalization, but it seems most likely that differences in the binding affinity between the two lectins are responsible for the differential effects, further supporting a specific role for fucosylated glycoconjugates in repair. Although it is possible for lectin binding to cells to either enhance or inhibit cell proliferation, we know from previous studies that proliferation does not play a significant role in epithelial repair in this system (16). This, together with the localization, time course of inhibition, and sensitivity to fucose blocking suggests a regulatory step in the migratory phase of repair involves fucose-containing glycoconjugates.
In human respiratory tract, Dorscheid and colleagues (11) have shown that AAL bound to the surface of nonsecretory columnar and basal epithelial cells but not to the basement membrane. In the same study, A. anguilla and L. tetragonolobus (both fucose specific) lectin binding sites were found on columnar, but not basal, cells, implicating a link between
1,6-fucose linkages and a differentiated epithelial cell phenotype. Our results indicating apical localization of AAL binding sites are consistent with this. In studies by the same authors, EGF-enhanced epithelial repair was inhibited by blocking integrin binding to collagen IV (40) or using wheat germ agglutinin lectin potentially via binding to
-dystroglycan (41). Using
1,6-fucosyltransferase null mice, Wang and colleagues (39) have shown that immunoprecipitated EGF receptor (EGFR) binds AAL and that this binding is reduced in the null mice, supporting the contention that AAL is binding
1,6-fucose. In their study,
1,6-fucosylation of the EGFR in embryonic fibroblasts was required for ligand binding to induce normal EGFR phosphorylation. Given the phosphorylation and increased expression of EGFR following epithelial damage and the associated effect in enhancing repair (29, 30, 40), AAL binding to EGFR could affect epithelial repair. The apical distribution of AAL-binding sites in undamaged cultures, where EGFR might be expected to be basolaterally localized, together with the similarity in distribution with damaged, repairing cultures suggests that other fucosylated molecules may also be important. At the patient level, Kauffmann and colleagues (18) have shown that the absence of Lewis antigens is associated with higher prevalence of asthma and wheezing, whereas Allahverdian et al. (4) suggest an essential function for sialyl LewisX in epithelial repair. The importance of AAL-binding, fucose-containing glycoconjugates in epithelial repair supports and extends our previous studies showing that lectin binding is not sufficient to inhibit damage repair but is dependent on the carbohydrate specificity of the lectin (1).
The importance of fucosylation in regulating protein activity has been shown in a number of studies. Increased H antigen levels in dermal wound healing (9) indicate a wound-related increase in the activity of the secretor-independent
1,2-fucosyltransferase. Fucose residues have also been implicated in the attachment of the bacterium Pseudomonas aeruginosa to airway epithelium. This bacterium produces a fucose-specific lectin (PA II) that inhibits the beating of airway cilia (2), which in vivo would result in mucus retention, making it easier for the bacteria to attach and replicate without being expelled. This action of PA II was shown to be inhibited by fucose addition. Furthermore, this effect of cessation of ciliary beating was also observed in cystic fibrosis (CF) patients (3). This group of patients normally exhibit colonization by P. aeruginosa at a fairly early age, and there is a constant problem in management of this disease. These results have demonstrated that there is potential for therapeutic treatment of these patients with fucose, as any reduction in the attachment of this bacterium could only be advantageous for CF patients. Using AAL as an immunosensor, fucosylation of
1-acid glycoprotein has been shown to increase with inflammation and rises in patients with severe burns (20). Serum glycoproteins have been shown to stimulate airway epithelial repair. Patchell and Dorscheid (28) have postulated that glycosylation of asthmatic airways may be altered by the immune response such that interaction with the serum proteins is reduced resulting in persistence of epithelial damage (19). Mouse monoclonal antibodies specific for the
1,6-fucose linkage (CAB2 and CAB4) have been used to show regulated expression of this fucose linkage in adhesion-related changes in Dictyostelium (8) and tissue-specific patterns of expression (33).
Changes in cell membrane carbohydrate antigens also play an important role in carcinogenesis and metastasis (24). Sialyl LewisA and sialyl LewisX antigens are commonly expressed on human cancer cells and are thought to be specifically involved in the binding of the cancer cells to the endothelium during metastatic tumor spread. As a consequence, the presence of these carbohydrate determinants can be used as a prognostic indicator of metastasis (17). Highly metastatic melanoma cells have an increased expression of the sialyl LewisX tetrasaccharide (26) on the cell surface and can be used to determine the metastatic potential of these cells. Increased expression of sialyl LewisX has also been seen in a number of other cancers including colorectal carcinoma (36), liver cancer (21), lung adenocarcinoma (14), and non-small cell carcinoma (31).
In conclusion, our studies implicate fucose-containing glycoconjugates on the surface of epithelial cells as key molecules in the repair of epithelial damage. This may have important implications for our understanding of respiratory disease and related inflammatory pathologies occurring at mucosal surfaces.
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
isoform release and activation during in vitro bronchial epithelial wound repair. Am J Physiol Lung Cell Mol Physiol 282: L115L123, 2002.This article has been cited by other articles:
![]() |
C. Coraux, J. Roux, T. Jolly, and P. Birembaut Epithelial Cell-Extracellular Matrix Interactions and Stem Cells in Airway Epithelial Regeneration Proceedings of the ATS, August 15, 2008; 5(6): 689 - 694. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |